FindTrial
Sign In

A multicentre, observational, real-world study with lung cancer brain metastases

A multicentre, observational, real-world study with lung cancer brain metastases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056528
Enrollment
Unknown
Registered
2022-02-07
Start date
2021-03-01
Completion date
Unknown
Last updated
2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer brain metastases

Interventions

Case series:None

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with lung cancer diagnosed pathologically, with or without symptoms and signs of brain metastasis, MRI and CT indicate single and multiple lesions in the brain, and brain metastasis of lung cancer can be diagnosed by excluding other conditions; 2. Aged >18 years; 3. At least one measurable lesion; 4. Understand the condition and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. No pathological evidence and follow-up can not be tracked; 2. The primary focus is unknown or other tumors are combined in recent 2 years; 3. Patients unable to cooperate with lung cancer treatment; 4. Patients with other diseases that seriously affect their lives, and the estimated survival time is less than 3 months; 5. Pregnant women and lactating patients.

Design outcomes

Primary

MeasureTime frame
Overall survival;Progression-free survival;—

Countries

China

Contacts

Public ContactLi Hongru

Fujian Provincial Hospital

muzi131122@fjmu.cn+86 18650308626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026